 Connection
James Bridges to Lung Diseases
This is a "connection" page, showing publications James Bridges has written about Lung Diseases.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.550 |
|
|
|
-
Ludwig MG, Seuwen K, Bridges JP. Adhesion GPCR Function in Pulmonary Development and Disease. Handb Exp Pharmacol. 2016; 234:309-327.
Score: 0.314
-
Bridges JP, Wert SE, Nogee LM, Weaver TE. Expression of a human surfactant protein C mutation associated with interstitial lung disease disrupts lung development in transgenic mice. J Biol Chem. 2003 Dec 26; 278(52):52739-46.
Score: 0.134
-
Saito A, Nikolaidis NM, Amlal H, Uehara Y, Gardner JC, LaSance K, Pitstick LB, Bridges JP, Wikenheiser-Brokamp KA, McGraw DW, Woods JC, Sabbagh Y, Schiavi SC, Altinisik G, Jakopovic M, Inoue Y, McCormack FX. Modeling pulmonary alveolar microlithiasis by epithelial deletion of the Npt2b sodium phosphate cotransporter reveals putative biomarkers and strategies for treatment. Sci Transl Med. 2015 Nov 11; 7(313):313ra181.
Score: 0.078
-
McCarthy C, Lee E, Bridges JP, Sallese A, Suzuki T, Woods JC, Bartholmai BJ, Wang T, Chalk C, Carey BC, Arumugam P, Shima K, Tarling EJ, Trapnell BC. Statin as a novel pharmacotherapy of pulmonary alveolar proteinosis. Nat Commun. 2018 08 07; 9(1):3127.
Score: 0.024
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|